Frailty in randomized controlled trials of glucose-lowering therapies for type 2 diabetes: An individual participant data meta-analysis of frailty prevalence, treatment efficacy, and adverse events.
Saved in:
| Title: | Frailty in randomized controlled trials of glucose-lowering therapies for type 2 diabetes: An individual participant data meta-analysis of frailty prevalence, treatment efficacy, and adverse events. |
|---|---|
| Authors: | Wightman, Heather1 (AUTHOR), Butterly, Elaine1 (AUTHOR), Wei, Lili1 (AUTHOR), McChrystal, Ryan1 (AUTHOR), Sattar, Naveed2 (AUTHOR), Adler, Amanda3 (AUTHOR), Phillippo, David4 (AUTHOR), Dias, Sofia5 (AUTHOR), Welton, Nicky4 (AUTHOR), Clegg, Andrew6 (AUTHOR), Witham, Miles7,8 (AUTHOR), Rockwood, Kenneth9 (AUTHOR), McAllister, David A.1 (AUTHOR), Hanlon, Peter1 (AUTHOR) Peter.hanlon@glasgow.ac.uk |
| Source: | PLoS Medicine. 4/7/2025, Vol. 22 Issue 4, p1-18. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 15491277 |
|---|---|
| DOI: | 10.1371/journal.pmed.1004553 |
